THE CODE: The Code is a three-part video series investigating the roots of today’s most promising genetic technologies
By Text: Sharon Begley Video: Retro Report,
STAT
| 04. 02. 2018
Those who do not remember the past are doomed to repeat it. And those who do not remember the sometimes irrational exuberance around past advances in biomedicine may be doomed to buy into the hype around today’s. From curing Alzheimer’s and Parkinson’s to eliminating cancer deaths, no goal has been too ambitious for the best minds in medicine to claim is within reach thanks to the latest scientific discovery.
Here is your genetic gut check.
This three-part series of documentary shorts, produced by Retro Report in partnership with STAT, looks back at the roots of three of today’s most promising genetic technologies: genetic testing to predict which diseases someone might develop, precision medicine to match people’s genes to the treatments most likely to work for them, and genome-editing via CRISPR to repair disease-causing genes. Watch and listen to experts explain how the 1980s and 1990s version of each was going to change medicine and save lives. It puts today’s promises in a whole new light.
PART 1

The race to sequence the human genome was also billed as a race...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...